Related Experiment Video

Updated: Jul 3, 2026

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Outcome of patients with stable angina pectoris treated with or without percutaneous coronary intervention

Ye Gu1, Yongjun Hu, Liqun Hu

  • 1Department of Cardiology, Puai Hospital, Huazhong University of Science and Technology, Wuhan, China. yegu2003cn@yahoo.com.cn

Cardiology Journal
|July 25, 2008
PubMed

Insights

Percutaneous coronary intervention (PCI) offers no additional benefit for stable angina patients already receiving optimal medical therapy. Outcomes were similar between PCI-treated and medically-treated groups over 24 months.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Stable angina pectoris is a common cardiovascular condition.
  • Optimal medical therapy is the cornerstone of management.
  • Percutaneous coronary intervention is a treatment option for coronary stenosis.

Purpose of the Study:

  • To compare outcomes of stable angina patients treated with percutaneous coronary intervention versus medical management.
  • To evaluate the 24-month major adverse cardiac events in these patient groups.

Main Methods:

  • Eighty patients with stable angina and confirmed coronary stenosis were included.
  • Patients were divided into two groups: percutaneous coronary intervention (n=31) and medical management (n=49).
  • All patients received optimal medical therapy and were followed for 24 months.

Main Results:

  • No significant differences in baseline characteristics or coronary lesion types were observed between groups.
  • Major adverse cardiac events occurred in 22.4% of the PCI group and 22.6% of the medical management group.
  • There was no statistically significant difference in outcomes between the two treatment strategies.

Conclusions:

  • Percutaneous coronary intervention did not demonstrate additional benefit over optimal medical therapy for stable angina patients.
  • Standard medical treatment appears sufficient for managing major adverse outcomes in this patient cohort over 24 months.
Abstract

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...